ClinicalTrials.Veeva

Menu

Incidence of Poorly Controlled Diabetes in Surgical Population

S

Singapore Health Services (SingHealth)

Status

Unknown

Conditions

Diabetes Mellitus

Treatments

Other: HbA1C

Study type

Observational

Funder types

Other

Identifiers

NCT04070963
201812-00075 C

Details and patient eligibility

About

Our study aims to determine the incidence of undiagnosed and poorly controlled diabetes among surgical patients in Singapore using preoperative HbA1c as a screening tool.

Full description

The study aims to determine the incidence of undiagnosed and poorly controlled diabetes among surgical patients in Singapore using preoperative HbA1c as a screening tool.

The investigators aim to follow up on the incidence of perioperative complications in this cohort. In the longer term, the investigators hope to evaluate the role of a preoperative diabetic screening and intervention program as an opportunistic "teachable moment" for surgical patients. This may help to achieve greater control of the disease burden in Singapore.

Specific aims:

Specific Aim 1: To establish the incidence of undiagnosed diabetes/prediabetes among surgical patients in Singapore, based on HbA1c level ≥ 6.1% prior to surgery Specific Aim 2: To establish the incidence of poorly-controlled diabetes among surgical patients in Singapore, based on HbA1c level ≥ 8% prior to surgery Specific Aim 3: To identify and characterize any association between preoperative HbA1c level and postoperative outcomes

Enrollment

888 estimated patients

Sex

All

Ages

21 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age >21 years old
  2. able to give informed consent
  3. Scheduled to have preoperative blood taken during clinic visit

Exclusion criteria

  1. Age < 21 years old
  2. unable to given informed consent
  3. Not required to have routine preoperative blood tests taken

Trial design

888 participants in 1 patient group

Cohort
Description:
We propose a prospective, observational single-centre pilot study in the PAC (SGH), on participants aged 21 years and above. A HbA1c test will be added to their routine preoperative blood tests. The incidence of newly-diagnosed DM/pre-diabetes (HbA1c ≥6.1%) and poorly controlled DM (HbA1c ≥ 8%), demographic details and presence of significant comorbidities will be analysed.
Treatment:
Other: HbA1C

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems